Decoding CKD Progression Through Biomarkers, Models & Emerging Mechanisms
- Leveraging validated biomarkers to accelerate preclinical target discovery and therapeutic decision making
- Using single-cell data to reveal how tubular, endothelial, inflammatory, and fibroblast cells drive disease
- Advancing in vivo models such as the db/db UNX renin AAV to explore incretin-based therapies for kidney health